Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Raily Aesthetic Medicine International Holdings Limited ( (HK:2135) ) has provided an update.
Raily Aesthetic Medicine International Holdings Limited reported its unaudited interim results for the six months ending June 30, 2025, revealing a significant decrease in revenue and an increased loss compared to the same period in 2024. The company experienced a drop in gross profit and other income, while expenses in selling, distribution, and administration also decreased. The overall loss for the period was attributed to both owners of the parent and non-controlling interests, indicating financial challenges that may impact stakeholders and the company’s market position.
More about Raily Aesthetic Medicine International Holdings Limited
Raily Aesthetic Medicine International Holdings Limited operates in the aesthetic medicine industry, focusing on providing aesthetic medical services and products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 460,476
Technical Sentiment Signal: Sell
Current Market Cap: HK$65.74M
For an in-depth examination of 2135 stock, go to TipRanks’ Overview page.